Mary Miller

CIK: 0001841088

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (16.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)16 (64.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ACRV

Acrivon Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (25 total)

ACRV
Acrivon Therapeutics, Inc.
Oct 22, 2026
Sale(S)
Direct
513 shares at avg. $1.84$943.92
ACRV
Acrivon Therapeutics, Inc.
Oct 5, 2026
Sale(S)
Direct
294 shares at avg. $1.99$585.06
ACRV
Acrivon Therapeutics, Inc.
Aug 18, 2026
Sale(S)
Direct
185 shares at avg. $2.01$371.85
ACRV
Acrivon Therapeutics, Inc.
Jul 21, 2026
Sale(S)
Direct
573 shares at avg. $1.76$1K
ACRV
Acrivon Therapeutics, Inc.
May 18, 2026
Award(A)
Direct
49.8K shares-
ACRV
Acrivon Therapeutics, Inc.
May 14, 2026
Tax Payment(F)
Direct
184 shares at avg. $1.92$353.28
ACRV
Acrivon Therapeutics, Inc.
Apr 17, 2026
Tax Payment(F)
Direct
558 shares at avg. $1.78$993.24
ACRV
Acrivon Therapeutics, Inc.
Mar 1, 2026
Award(A)
Stock Option (Right to Buy)
Direct
129.8K shares-
ACRV
Acrivon Therapeutics, Inc.
Feb 14, 2026
Tax Payment(F)
Direct
217 shares at avg. $1.63$353.71
ACRV
Acrivon Therapeutics, Inc.
Jan 17, 2026
Tax Payment(F)
Direct
659 shares at avg. $1.98$1K
ACRV
Acrivon Therapeutics, Inc.
Nov 14, 2025
Tax Payment(F)
Direct
184 shares at avg. $2.24$412.16
ACRV
Acrivon Therapeutics, Inc.
Oct 17, 2025
Tax Payment(F)
Direct
558 shares at avg. $1.81$1K
ACRV
Acrivon Therapeutics, Inc.
Oct 1, 2025
Tax Payment(F)
Direct
284 shares at avg. $1.81$514.04
ACRV
Acrivon Therapeutics, Inc.
Aug 14, 2025
Tax Payment(F)
Direct
184 shares at avg. $1.39$255.76
ACRV
Acrivon Therapeutics, Inc.
Jul 17, 2025
Tax Payment(F)
Direct
558 shares at avg. $1.32$736.56
ACRV
Acrivon Therapeutics, Inc.
May 14, 2025
Tax Payment(F)
Direct
184 shares at avg. $1.14$209.76
ACRV
Acrivon Therapeutics, Inc.
Apr 17, 2025
Tax Payment(F)
Direct
558 shares at avg. $1.81$1K
ACRV
Acrivon Therapeutics, Inc.
Apr 1, 2025
Award(A)
Stock Option (Right to Buy)
Direct
15.6K shares-
ACRV
Acrivon Therapeutics, Inc.
Mar 1, 2025
Award(A)
Stock Option (Right to Buy)
Direct
93.7K shares-
ACRV
Acrivon Therapeutics, Inc.
Feb 14, 2025
Tax Payment(F)
Direct
217 shares at avg. $5.42$1K
ACRV
Acrivon Therapeutics, Inc.
Jan 17, 2025
Tax Payment(F)
Direct
659 shares at avg. $5.78$4K
ACRV
Acrivon Therapeutics, Inc.
Nov 14, 2024
Tax Payment(F)
Direct
184 shares at avg. $7.92$1K
ACRV
Acrivon Therapeutics, Inc.
Oct 17, 2024
Tax Payment(F)
Direct
558 shares at avg. $7.87$4K
ACRV
Acrivon Therapeutics, Inc.
Oct 1, 2024
Tax Payment(F)
Direct
284 shares at avg. $6.98$2K
ACRV
Acrivon Therapeutics, Inc.
Mar 1, 2024
Award(A)
Stock Option (Right to Buy)
Direct
67.6K shares-

		Type	Shares	Price		Ownership
Oct 22, 2026	ACRV Acrivon Therapeutics, Inc.	Sale(S)	513	$1.84	$944	Direct
Oct 5, 2026	ACRV Acrivon Therapeutics, Inc.	Sale(S)	294	$1.99	$585	Direct
Aug 18, 2026	ACRV Acrivon Therapeutics, Inc.	Sale(S)	185	$2.01	$372	Direct
Jul 21, 2026	ACRV Acrivon Therapeutics, Inc.	Sale(S)	573	$1.76	$1,008	Direct
May 18, 2026	ACRV Acrivon Therapeutics, Inc.	Award(A)	49,830	-	$0	Direct
May 14, 2026	ACRV Acrivon Therapeutics, Inc.	Tax Payment(F)	184	$1.92	$353	Direct
Apr 17, 2026	ACRV Acrivon Therapeutics, Inc.	Tax Payment(F)	558	$1.78	$993	Direct
Mar 1, 2026	ACRV Acrivon Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	129,760	-	-	Direct
Feb 14, 2026	ACRV Acrivon Therapeutics, Inc.	Tax Payment(F)	217	$1.63	$354	Direct
Jan 17, 2026	ACRV Acrivon Therapeutics, Inc.	Tax Payment(F)	659	$1.98	$1,305	Direct
Nov 14, 2025	ACRV Acrivon Therapeutics, Inc.	Tax Payment(F)	184	$2.24	$412	Direct
Oct 17, 2025	ACRV Acrivon Therapeutics, Inc.	Tax Payment(F)	558	$1.81	$1,010	Direct
Oct 1, 2025	ACRV Acrivon Therapeutics, Inc.	Tax Payment(F)	284	$1.81	$514	Direct
Aug 14, 2025	ACRV Acrivon Therapeutics, Inc.	Tax Payment(F)	184	$1.39	$256	Direct
Jul 17, 2025	ACRV Acrivon Therapeutics, Inc.	Tax Payment(F)	558	$1.32	$737	Direct
May 14, 2025	ACRV Acrivon Therapeutics, Inc.	Tax Payment(F)	184	$1.14	$210	Direct
Apr 17, 2025	ACRV Acrivon Therapeutics, Inc.	Tax Payment(F)	558	$1.81	$1,010	Direct
Apr 1, 2025	ACRV Acrivon Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	15,616	-	-	Direct
Mar 1, 2025	ACRV Acrivon Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	93,693	-	-	Direct
Feb 14, 2025	ACRV Acrivon Therapeutics, Inc.	Tax Payment(F)	217	$5.42	$1,176	Direct
Jan 17, 2025	ACRV Acrivon Therapeutics, Inc.	Tax Payment(F)	659	$5.78	$3,809	Direct
Nov 14, 2024	ACRV Acrivon Therapeutics, Inc.	Tax Payment(F)	184	$7.92	$1,457	Direct
Oct 17, 2024	ACRV Acrivon Therapeutics, Inc.	Tax Payment(F)	558	$7.87	$4,391	Direct
Oct 1, 2024	ACRV Acrivon Therapeutics, Inc.	Tax Payment(F)	284	$6.98	$1,982	Direct
Mar 1, 2024	ACRV Acrivon Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	67,567	-	-	Direct

1-25 of 25 transactions

About Miller Mary

Miller Mary (SEC CIK 0001841088) files insider reports with the SEC as Chief Legal Officer of Acrivon Therapeutics, Inc. (ACRV).

Signal8 holds 25 ownership filings by Miller Mary, all Form 4s, filed between Oct 3, 2024 and Oct 26, 2026. Those filings report 25 transactions, from Mar 1, 2024 to Oct 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Miller Mary's filings is in WATERTOWN, MA.

Recent filings by Miller Mary

Oct 22, 2026: Open-market sale of ACRV shares (Form 4, code S).
Oct 5, 2026: Open-market sale of ACRV shares (Form 4, code S).
Aug 18, 2026: Open-market sale of ACRV shares (Form 4, code S).
Jul 21, 2026: Open-market sale of ACRV shares (Form 4, code S).
May 18, 2026: Grant or award of ACRV shares (Form 4, code A).

Other insiders filing for Acrivon Therapeutics, Inc. (ACRV)

Levin Michaela, Chief Business Officer
Blume-Jensen Peter, President and CEO
Peterson Katharine, Chief Accounting Officer
Gamelin Erick, Chief Development Officer
Devroe Eric, Chief Operating Officer
Levy Adam D., Chief Financial Officer

How to read Form 4 transaction codes